Michał Bado

Michał Bado

Auto-generated profile, based on publicly available information

Michał Bado

The University Hospital in Krakow, Jakubowskiego 2 Street, 30-688 Krakow, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
HGHubert Gugulski
Hubert Gugulski
MKMichał Andrzej Kozicz
Michał Andrzej Kozicz
SRSzymon Rudawski
Szymon Rudawski
ŁWŁukasz Wójcik
Łukasz Wójcik
MZMagdalena Zięba
Magdalena Zięba
KBKrzysztof Bilecki
Krzysztof Bilecki
Introduction: Nicotinamide mononucleotide (NMN) is a supplement that can boost nicotinamide adenine dinucleotide (NAD+) levels in the body, which is crucial for maintaining energy balance and stress response. Declining NAD+ levels with age contribute to aging and related diseases, making NMN supplementation a potential solution. Despite its potential benefits, NMN’s safety and efficacy need further investigation. Aim of the Study: This study aimed to analyze recent research on NMN supplementation regarding its safety and efficacy in improving human health, especially in patients with diabetes and prediabetes, and to suggest potential research directions for this compound. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, focusing on literature from the past 5 years, primarily on randomized controlled trials. The databases were searched using the term “nicotinamide mononucleotide” to gather articles, and references from selected articles were included. Conclusion: A beneficial direction for NMN research is an in-depth analysis of its effects on skeletal muscles in both healthy individuals and those with diabetes. Studies on larger groups, with higher doses, and over longer periods are crucial to determine the optimal supplementation protocol and assess individual variability in NMN’s metabolic effects.

10 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MKMichał Andrzej Kozicz
Michał Andrzej Kozicz
PCPaulina Cuper
Paulina Cuper
IJIlona Jastrzębska
Ilona Jastrzębska
KBKrzysztof Bilecki
Krzysztof Bilecki
HGHubert Gugulski
Hubert Gugulski
MCMichalina Cuper
Michalina Cuper
Introduction: The Dark Triad is a construct devised by Paulhus and Williams in 2002. It comprises of three personality disorders: Narcissism, Machiavellianism and psychopathy, that are believed to be debilitating both to people exhibiting these traits and their social environment. Aim of the Study: The aim of the study was to collect and analyse current literature regarding the Dark Triad and the influence of its components on different areas of functioning. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, with the primary focus on literature from the past 5 years. These databases were searched using “the Dark Triad” and its components names as entries to gather articles. Additionally, references from selected articles were included in the analysis. Results: Our article showed that the components of the Dark Triad influence many areas of functioning, although this influence is not always negative. Having all the traits of the Dark Triad is more likely to induce immoral behaviour than having the individual traits in isolation. Thus, further research of the Dark Triad is needed, especially regarding different facets of its components. Devising more in-depth questionnaires that would cover all sub-divisions of the Dark Triad components would largely bolster the research in this field.

28 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PCPaulina Cuper
Paulina Cuper
PPPiotr Pawłucki
Piotr Pawłucki
AMAnna Maciak
Anna Maciak
MKMichał Andrzej Kozicz
Michał Andrzej Kozicz
IJIlona Jastrzębska
Ilona Jastrzębska
MSMichał Jakub Sekuła
Michał Jakub Sekuła
Background Minoxidil and platelet-rich plasma (PRP) are proven treatments for androgenetic alopecia, however their combined therapy is not as researched. Research materials and methods Materials used for our research consist of published papers that pertain to both minoxidil and platelet-rich plasma therapies. More comprehensive papers, such as those including other substances were also included although results about other substances were not included, we simply discarded them. Each of the found and chosen articles were added and processed by various formulas which aim were to calculate efficacy of combined therapy while minimizing the errors and biases that could prop up in the source papers. Overall goal was to consolidate knowledge of the efficacy of combined therapy of minoxidil and platelet-rich plasma with emphasis on effect that could affect the physical performance. Results All trials have shown statistically significant improvement when compared to minoxidil monotherapy. Compared to PRP monotherapy results had been superior although not always in statistically significant manner. No trials have shown additional, adverse interactions, side effects or impacts on physical performance beyond those expected from the monotherapies, proving combined is as safe as monotherapies. Conclusion Combined therapy is proven to yield better results, while remaining a safe and cost-effective method. It doesn’t impact physical performance in any way if taken correctly. Still higher quantity of research is welcome to make those finding more stable and in order to better assess the positive effect of combing titular substances.

18 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
IJIlona Jastrzębska
Ilona Jastrzębska
PCPaulina Cuper
Paulina Cuper
MKMichał Andrzej Kozicz
Michał Andrzej Kozicz
KBKrzysztof Bilecki
Krzysztof Bilecki
HGHubert Gugulski
Hubert Gugulski
PNPatrycja Nowoświat
Patrycja Nowoświat
Introduction: Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder, in which the central clinical characteristics are hyperphagia and obesity. Obesity leads to higher mortality rates in PWS patients and thus, effective and safe treatment of hyperphagia and obesity in PWS individuals is an important aspect of PWS therapy. Aim of the study: The aim of the study was to research both the new and the more standard treatment options of hyperphagia and obesity in PWS patients. Methods and Materials: An extensive literature search was conducted using PubMed database. Only articles from the past 5 years were taken into consideration. The keywords used during the search were: prader willi syndrome, obesity, treatment. Results: Our research showed that in the treatment of hyperphagia and obesity in PWS patients, health professionals may consider the use of pharmacological treatment options, surgery and neuromodulatory options. Moreover, physical activity and environmental control are beneficial in limiting caloric intake and improving body mass index. Furthermore, early diagnosis and thus starting treatment in early childhood are beneficial in preventing the progression of obesity. However, more research is needed to determine which treatment options are best suited for specific patients.

19 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PNPatrycja Nowoświat
Patrycja Nowoświat
MMMaria Maślankiewicz
Maria Maślankiewicz
MMMagdalena Muzyk
Magdalena Muzyk
PMPatrycja Mrowczyk
Patrycja Mrowczyk
MBMichał Bado
Michał Bado
KBKrzysztof Bilecki
Krzysztof Bilecki
Introduction: Myxoedema coma is a severe and rare manifestation of hypothyroidism that requires immediate and effective intervention. Traditional treatment involves the use of levothyroxine, a synthetic thyroid hormone. Liquid levothyroxine presents an alternative formulation that may offer advantages in the critical care setting, particularly when gastrointestinal absorption is impaired. Aim of the Study: This narrative review aims to evaluate the efficacy and application of liquid levothyroxine in the treatment of myxoedema coma, comparing it to other available forms and providing insights into its clinical use. Materials and Methods: A comprehensive literature search was conducted using databases such as PubMed, Medline, and Cochrane Library. Studies, clinical trials, case reports, and reviews were included if they addressed the use of liquid levothyroxine in myxoedema coma. Data were extracted and analyzed to assess the pharmacokinetics, administration protocols, outcomes, and comparative efficacy of liquid levothyroxine. Results: The review identified several key studies and case reports indicating that liquid levothyroxine offers superior bioavailability and faster onset of action compared to oral tablets, particularly in patients with compromised gastrointestinal function. Case studies demonstrated improved clinical outcomes and recovery times with liquid levothyroxine, highlighting its potential benefits in the acute management of myxoedema coma. Conclusion: Liquid levothyroxine appears to be a promising alternative for the treatment of myxoedema coma, offering enhanced absorption and rapid therapeutic effects. While preliminary data are encouraging, further research and clinical trials are necessary to establish standardized treatment protocols and confirm its efficacy. Understanding the role of liquid levothyroxine in this critical condition can enhance treatment strategies and improve patient outcomes.

31 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
SPSandra Agnieszka Pilawska
Sandra Agnieszka Pilawska
MBMichał Bado
Michał Bado
MGMichał Goncerz
Michał Goncerz
PNPatrycja Nowoświat
Patrycja Nowoświat
KBKrzysztof Bilecki
Krzysztof Bilecki
MMMaria Maślankiewicz
Maria Maślankiewicz
Introduction: Traumatic brain injury (TBI) is one of the most common causes of death and long-term disability. The consequences following TBI can be persistent and cause life-long implications for survivors. Treatment of TBI may be complex and involve large monetary costs. The frequent injury mechanisms are traffic-related, falls, violence or sport-related accidents. Higher risk of brain injury and its complications indicate that people affected by brain trauma may benefit from the prophylactic and post-traumatic use of certain supplements both in the context of physical performance and in the event of potential injury. Aim of the Study: This narrative review examines the current literature of the role of supplementation before and after TBI and its effects on the patient's outcome. Materials and Methods: A comprehensive search was performed using PubMed and Google Scholar focusing on the literature published up to April 2024. The review included randomized controlled trials, meta-analyses, systematic reviews that focused on the use of creatine monohydrate, omega-3 fatty acids, magnesium and zinc in TBI and among the general population. Data of pathophysiology and epidemiology of TBI and safety profile of supplements were involved. Results: The evidence indicates that the role of supplementation with creatine, omega-3 PUFAs and zinc is important in mitigating secondary damage after TBI, as well as in protecting against damage if administered before injury. Conclusion: Because of the complex and multifactorial nature of the TBI more studies are required to constitute an effective nutrition-based strategy for reducing the cognitive and behavioral deficits associated with this injury. The evidence supporting multiple dietary components to improve a patient's outcome seems strong and the cost of its implementation is low. A group of particular interest that may benefit additionally are athletes who use dietary supplementation in their daily routine.